{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:00:28Z","timestamp":1791644428731,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.virol.2019.12.005","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T08:07:58Z","timestamp":1576138078000},"page":"20-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["A novel human monoclonal antibody potently neutralizes human adenovirus serotype 7 by primarily targeting the adenovirus hexon protein"],"prefix":"10.1016","volume":"543","author":[{"given":"Jiansheng","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhou","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peitang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2019.12.005_bib1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1084\/jem.159.1.208","article-title":"Epstein-Barr virus susceptibility of normal human B lymphocyte populations","volume":"159","author":"Aman","year":"1984","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2019.12.005_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jcv.2011.11.001","article-title":"Molecular typing of adenoviruses in pediatric respiratory infections in Buenos Aires, Argentina (1999-2010)","volume":"53","author":"Barrero","year":"2012","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.virol.2019.12.005_bib3","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1073\/pnas.85.11.3995","article-title":"Human monoclonal antibodies produced by primary in vitro immunization of peripheral blood lymphocytes","volume":"85","author":"Borrebaeck","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2019.12.005_bib4","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/JVI.06165-11","article-title":"Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions","volume":"86","author":"Bradley","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.12.005_bib5","article-title":"Adenoviruses associated with acute respiratory diseases reported in beijing from 2011 to 2013","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2019.12.005_bib6","first-page":"2331","article-title":"Epidemiology and transmission characteristics of human adenovirus type 7 caused acute respiratory disease outbreak in military trainees in East China","volume":"8","author":"Cheng","year":"2016","journal-title":"Am. J. Tourism Res."},{"key":"10.1016\/j.virol.2019.12.005_bib7","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.4049\/jimmunol.143.5.1543","article-title":"Epstein-Barr virus preferentially induces proliferation of primed B cells","volume":"143","author":"Crain","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2019.12.005_bib8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/JVI.06593-11","article-title":"Five genome sequences of subspecies B1 human adenoviruses associated with acute respiratory disease","volume":"86","author":"Dehghan","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.12.005_bib9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.virol.2018.03.002","article-title":"Hexon and fiber of adenovirus type 14 and 55 are major targets of neutralizing antibody but only fiber-specific antibody contributes to cross-neutralizing activity","volume":"518","author":"Feng","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.virol.2019.12.005_bib10","doi-asserted-by":"crossref","first-page":"282","DOI":"10.7883\/yoken.67.282","article-title":"A novel complex recombinant form of type 48-related human adenovirus species D isolated in Japan","volume":"67","author":"Fujimoto","year":"2014","journal-title":"Jpn. J. Infect. Dis."},{"key":"10.1016\/j.virol.2019.12.005_bib11","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1128\/jvi.70.4.2116-2123.1996","article-title":"Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes","volume":"70","author":"Gall","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.12.005_bib12","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s10096-011-1406-8","article-title":"Detection of three human adenovirus species in adults with acute respiratory infection in China","volume":"31","author":"Guo","year":"2012","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.virol.2019.12.005_bib13","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.vaccine.2012.12.029","article-title":"History of the restoration of adenovirus type 4 and type 7 vaccine, live oral (Adenovirus Vaccine) in the context of the Department of Defense acquisition system","volume":"31","author":"Hoke","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2019.12.005_bib14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jcv.2005.11.008","article-title":"Emergence of a new human adenovirus type 4 (Ad4) genotype: identification of a novel inverted terminal repeated (ITR) sequence from majority of Ad4 isolates from US military recruits","volume":"35","author":"Houng","year":"2006","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.virol.2019.12.005_bib15","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.copbio.2007.10.011","article-title":"Human monoclonal antibodies by immortalization of memory B cells","volume":"18","author":"Lanzavecchia","year":"2007","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.virol.2019.12.005_bib16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/rmv.589","article-title":"Clinical features and treatment of adenovirus infections","volume":"18","author":"Lenaerts","year":"2008","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.virol.2019.12.005_bib17","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/infdis\/jiw423","article-title":"Current status of dengue therapeutics research and development","volume":"215","author":"Low","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2019.12.005_bib18","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3389\/fmicb.2018.01214","article-title":"Potent neutralization ability of a human monoclonal antibody against serotype 1 dengue virus","volume":"9","author":"Lu","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virol.2019.12.005_bib19","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/JVI.02023-06","article-title":"Structure-based identification of a major neutralizing site in an adenovirus hexon","volume":"81","author":"Pichla-Gollon","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.12.005_bib20","doi-asserted-by":"crossref","first-page":"7964","DOI":"10.1128\/JVI.07076-11","article-title":"Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regions","volume":"86","author":"Qiu","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.12.005_bib21","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/cid\/ciu507","article-title":"Dramatic decline of respiratory illness among US military recruits after the renewed use of adenovirus vaccines","volume":"59","author":"Radin","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virol.2019.12.005_bib22","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.virol.2019.12.005_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/srep01812","article-title":"Molecular evolution of human adenoviruses","volume":"3","author":"Robinson","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2019.12.005_bib24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.virol.2004.12.029","article-title":"Use of chimeric adenoviral vectors to assess capsid neutralization determinants","volume":"333","author":"Roy","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.virol.2019.12.005_bib25","doi-asserted-by":"crossref","first-page":"9553","DOI":"10.1128\/JVI.77.17.9553-9566.2003","article-title":"Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution X-ray crystallographic, molecular modeling, and sequence-based methods","volume":"77","author":"Rux","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.12.005_bib26","doi-asserted-by":"crossref","DOI":"10.1007\/s11908-014-0416-y","article-title":"Adenovirus: current epidemiology and emerging approaches to prevention and treatment","volume":"16","author":"Sandkovsky","year":"2014","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.virol.2019.12.005_bib27","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3201\/eid2206.151898","article-title":"Human adenovirus associated with severe respiratory infection, Oregon, USA, 2013-2014","volume":"22","author":"Scott","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virol.2019.12.005_bib28","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nprot.2009.3","article-title":"Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen","volume":"4","author":"Smith","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.virol.2019.12.005_bib29","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1556\/OH.2012.29496","article-title":"Adenovirus infections in immuncompromised patients","volume":"153","author":"Stercz","year":"2012","journal-title":"Orv. Hetil."},{"key":"10.1016\/j.virol.2019.12.005_bib30","article-title":"Human adenovirus serotype 3 vector packaged by a rare serotype 14 hexon","volume":"11","author":"Su","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2019.12.005_bib31","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.4049\/jimmunol.174.11.7179","article-title":"Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein","volume":"174","author":"Sumida","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2019.12.005_bib32","first-page":"206","article-title":"Broadly neutralizing monoclonal antibodies against human adenovirus types 55, 14p, 7, and 11 generated with recombinant type 11 fiber knob","volume":"7","author":"Tian","year":"2018","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.virol.2019.12.005_bib33","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.3390\/v7102896","article-title":"Identification and application of neutralizing epitopes of human adenovirus type 55 hexon protein","volume":"7","author":"Tian","year":"2015","journal-title":"Viruses-Basel"},{"key":"10.1016\/j.virol.2019.12.005_bib34","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.virusres.2011.06.017","article-title":"Construction and characterization of human adenovirus serotype 3 packaged by serotype 7 hexon","volume":"160","author":"Tian","year":"2011","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2019.12.005_bib35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","article-title":"Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning","volume":"329","author":"Tiller","year":"2008","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.virol.2019.12.005_bib36","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1128\/JVI.06075-11","article-title":"Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans","volume":"86","author":"Wrammert","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.12.005_bib37","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nature06890","article-title":"Rapid cloning of high-affinity human monoclonal antibodies against influenza virus","volume":"453","author":"Wrammert","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.virol.2019.12.005_bib38","doi-asserted-by":"crossref","first-page":"12775","DOI":"10.1128\/JVI.76.24.12775-12782.2002","article-title":"Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexon","volume":"76","author":"Wu","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.12.005_bib39","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.virol.2012.12.014","article-title":"Characteristics of neutralizing antibodies to adenovirus capsid proteins in human and animal sera","volume":"437","author":"Yu","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.virol.2019.12.005_bib40","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1016\/j.vaccine.2009.06.041","article-title":"Molecular modeling and epitopes mapping of human adenovirus type 3 hexon protein","volume":"27","author":"Yuan","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2019.12.005_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085094","article-title":"Pandemic influenza virus 2009 H1N1 and adenovirus in a high risk population of young adults: epidemiology, comparison of clinical presentations, and coinfection","volume":"9","author":"Yun","year":"2014","journal-title":"PLoS One"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682219303472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682219303472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:51:05Z","timestamp":1758588665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682219303472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":41,"alternative-id":["S0042682219303472"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2019.12.005","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel human monoclonal antibody potently neutralizes human adenovirus serotype 7 by primarily targeting the adenovirus hexon protein","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2019.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}